HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
Paul M Ridker, Jacques Genest, S Matthijs Boekholdt, Peter Libby, Antonio M Gotto, Børge G Nordestgaard, Samia Mora, Jean G MacFadyen, Robert J Glynn, John JP KasteleinVolume:
376
Year:
2010
Language:
english
DOI:
10.1016/s0140-6736(10)60713-1
File:
PDF, 144 KB
english, 2010